Understanding Sarcoidosis diagnosis, symptoms, and treatment is crucial for accurate clinical documentation and medical coding. This resource provides information on Sarcoidosis ICD-10 codes, SNOMED CT codes, differential diagnosis, stages of Sarcoidosis, pulmonary Sarcoidosis, and extrapulmonary manifestations. Learn about the latest research, clinical trials, and best practices for managing Sarcoidosis in healthcare settings. Explore resources for patients, healthcare providers, and coding specialists seeking accurate and comprehensive information on Sarcoidosis.
Also known as
Sarcoidosis
Covers all types and locations of sarcoidosis.
Respiratory conditions
Includes pulmonary sarcoidosis, affecting lungs.
Diseases of digestive system
May include sarcoidosis affecting digestive organs.
Diseases of the circulatory system
Can be used for cardiac sarcoidosis.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is sarcoidosis confirmed?
Yes
Organ involvement specified?
No
Do not code sarcoidosis. Code signs/symptoms or suspected diagnosis.
When to use each related code
| Description |
|---|
| Sarcoidosis: Inflammatory disease affecting multiple organs. |
| Hypersensitivity Pneumonitis: Lung inflammation due to inhaled antigens. |
| Tuberculosis: Infectious disease caused by Mycobacterium tuberculosis. |
Coding sarcoidosis without specifying the affected organ system (e.g., lung, skin) leads to inaccurate data and reimbursement issues. Use specific ICD-10-CM codes (D86.0-D86.9).
Lack of proper clinical documentation to support the sarcoidosis diagnosis can cause coding errors and compliance risks. CDI specialists must query for specificity.
Incorrectly coding unrelated conditions as manifestations of sarcoidosis leads to inflated case complexity and potential fraud. Ensure accurate documentation links comorbidities.
Patient presents with suspected sarcoidosis based on clinical presentation and preliminary investigations. Symptoms include persistent cough, dyspnea, fatigue, and bilateral hilar lymphadenopathy observed on chest radiograph. Differential diagnosis includes other granulomatous diseases such as tuberculosis, histoplasmosis, and lymphoma. Pulmonary sarcoidosis is the primary working diagnosis given the patient's respiratory symptoms and radiological findings. Further evaluation including pulmonary function tests, high-resolution computed tomography of the chest, and possible bronchoscopy with endobronchial ultrasound-guided transbronchial needle aspiration or biopsy is warranted to confirm the diagnosis and assess disease extent. Serum angiotensin-converting enzyme levels and serum calcium levels will be obtained. Patient education regarding sarcoidosis symptoms, staging, prognosis, and treatment options will be provided. Treatment plan may involve corticosteroids, such as prednisone, or other immunosuppressants if indicated by disease severity and progression. Patient will be monitored for treatment response and potential complications, including pulmonary fibrosis, cardiac involvement, ocular manifestations, and neurosarcoidosis. Follow-up appointments will be scheduled to monitor disease activity and adjust treatment as needed. ICD-10 code D86.9, sarcoidosis, unspecified, is the current presumptive diagnosis code. This diagnosis may be updated pending further diagnostic testing results. The medical decision-making complexity is currently moderate given the need to differentiate sarcoidosis from other granulomatous diseases. This documentation supports medical necessity for the ordered tests and procedures.